Lymphoma.
Mugnaini EN, Ghosh N.
Prim Care. 2016 Dec;43(4):661-675. doi: 10.1016/j.pop.2016.07.012.
Childhood aggressive B-cell non-Hodgkin lymphoma in low-middle-income countries.
Moleti ML, Testi AM, Foà R.
Br J Haematol. 2022 Feb;196(4):849-863. doi: 10.1111/bjh.17979. Epub 2021 Dec 6.
Aggressive non-Hodgkin lymphoma in the pediatric and young adult population; diagnostic and molecular pearls of wisdom.
Singh A, Obiorah IE.
Semin Diagn Pathol. 2023 Nov;40(6):392-400. doi: 10.1053/j.semdp.2023.06.002. Epub 2023 Jun 22.
How we treat NK/T-cell lymphomas.
Tse E, Zhao WL, Xiong J, Kwong YL.
J Hematol Oncol. 2022 Jun 3;15(1):74. doi: 10.1186/s13045-022-01293-5.
Strategies for aggressive T-cell lymphoma: divide and conquer.
Pinter-Brown LC.
Hematology Am Soc Hematol Educ Program. 2020 Dec 4;2020(1):154-159. doi: 10.1182/hematology.2020000101.
Non-Hodgkin lymphoma.
Evans LS, Hancock BW.
Lancet. 2003 Jul 12;362(9378):139-46. doi: 10.1016/S0140-6736(03)13868-8.
Aggressive Mediastinal Lymphomas.
Wang X, Wang W, Vega F, Quesada AE.
Semin Diagn Pathol. 2024 May;41(3):125-139. doi: 10.1053/j.semdp.2021.06.010. Epub 2021 Jun 16.
Clinical Applications of the Genomic Landscape of Aggressive Non-Hodgkin Lymphoma.
Moffitt AB, Dave SS.
J Clin Oncol. 2017 Mar 20;35(9):955-962. doi: 10.1200/JCO.2016.71.7603. Epub 2017 Feb 13.
Circulating Tumor DNA as Measurable Residual Disease in Aggressive B-Cell Lymphoma: A Narrative Review.
Roschewski M, Longo DL, Armitage JO.
JAMA Oncol. 2025 Apr 1;11(4):416-422. doi: 10.1001/jamaoncol.2024.6144.
Treatment of aggressive non-Hodgkin's lymphoma.
Coiffier B.
Semin Oncol. 1999 Oct;26(5 Suppl 14):12-20.
